Cecors Inc Stock Today

CEOS Stock  USD 0.03  0  8.57%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Over 79

 
High
 
Low
High
CeCors is selling for under 0.0288 as of the 22nd of November 2024; that is 8.57 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0256. CeCors has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for CeCors Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. More on CeCors Inc

Moving against CeCors Pink Sheet

  0.63ADSK AutodeskPairCorr
  0.52ALAB Astera Labs, Common Tech BoostPairCorr
  0.34DECK Deckers OutdoorPairCorr
  0.32ISRG Intuitive Surgical Fiscal Year End 28th of January 2025 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

CeCors Pink Sheet Highlights

Chairman, CEO and PresJames Fiedler
Business ConcentrationMedical Instruments & Supplies, Healthcare (View all Sectors)
CeCors Inc [CEOS] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 14.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CeCors's market, we take the total number of its shares issued and multiply it by CeCors's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CeCors Inc conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. CeCors Inc currently holds about 57.42 K in cash with (6.88 M) of positive cash flow from operations.
Check CeCors Probability Of Bankruptcy

CeCors Inc Risk Profiles

CeCors Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in CeCors without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

CeCors Corporate Management

Additional Tools for CeCors Pink Sheet Analysis

When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.